The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Vascular cognitive impairment
Abstract
Cerebrovascular disease is the second most common cause of acquired cognitive impairment and dementia and contributes to cognitive decline in the neurodegenerative dementias. The current narrow definitions of vascular dementia should be broadened to recognise the important part cerebrovascular disease plays in several cognitive disorders, including the hereditary vascular dementias, multi-infarct dementia, post-stroke dementia, subcortical ischaemic vascular disease and dementia, mild cognitive impairment, and degenerative dementias (including Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies). Here we review the current state of scientific knowledge on the subject of vascular brain burden. Important non-cognitive features include depression, apathy, and psychosis. We propose use of the term vascular cognitive impairment, which is characterised by a specific cognitive profile involving preserved memory with impairments in attentional and executive functioning. Diagnostic criteria have been proposed for some subtypes of vascular cognitive impairment, and there is a pressing need to validate and further refine these. Clinical trials in vascular cognitive impairment are in their infancy but support the value of therapeutic interventions for symptomatic treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cerebrovascular disease can also cause mild cognitive deficits that can affect multiple cognitive functions”
In the citing paper
“Aspects that argue for a relationship include extensive (multiple or large) vascular lesions (infarcts, hemorrhages, white matter lesions [WML]), lesions in strategic brain regions, signs of cerebral amyloid angiopathy (CAA) on neuroimaging, and specific clinical features, such as a stepwise decline of cognitive functions or prominent deficits of executive functions and processing speed. 26”
From Vascular Cognitive Impairment (2017) · cites this paper as [26]
In the citing paper
“A considerable body of literature has concluded that the preponderance of disturbance in vascular cognitive disorders is in processing speed and frontal-executive functions, manifesting as slowed information processing, poorer working memory and reduced set-shifting ability.10,14”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [10]
In the citing paper
“Cognitive disorders of vascular etiology are a heterogeneous group of disorders with diverse pathologies and clinical manifestations, discussed broadly under the rubric of vascular cognitive disorders (VCD).”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [10]
In the citing paper
“Evidence for significant vascular pathology in the brain usually relies on computed tomography (CT) or structural magnetic resonance imaging (MRI), with the latter being more sensitive, especially if the standardized protocols recommended by the harmonization group are followed.10”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [10]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Self-citationPlasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237
Frontal-subcortical circuits and human behavior
Cummings, J. L. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540080076020 · Cited by 2,262
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Statins and the risk of dementia
Jick, H., Zornberg, G., Jick, S., Seshadri, S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,759
15-year longitudinal study of blood pressure and dementia
Skoog, I., Nilsson, L., Persson, G., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L.-A., Odén, A., & Svanborg, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90608-x · Cited by 1,726
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
Chui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992) · Neurology · doi:10.1212/wnl.42.3.473 · Cited by 1,201
Research works printed but not linked: 7
- Hachinski, 1974, When vascular disease is responsible for dementia it is through the occurrence of multiple small or large cerebral infarcts, Lancet, 2, 207, 10.1016/s0140-6736(74)91496-2 · DOI · Paper page
- Premkumar, 1996, Apolipoprotein E e4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology in Alzheimer's disease, Am J Pathol, 148, 2083
- Roman, 1993, Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN international workshop, Neurology, 43, 250, 10.1212/wnl.43.2.250 · DOI · Paper page
- Orgogozo J-M, Rigaud A-S, Stöffler A, Möbius H-J, Forette F. Efficacy and safety of Mementaine in patients with mild to moderate vascular dementia: a randomised, placebo-controlled trial (MMM 300). Stroke (in press).
- Lopez-Arrieta BJ. Nimodipine for primary degenerative, mixed and vascular dementia (Cochrane Review). Cochrane Database Syst Rev 2001;1:CD000147.
- Erkinjuntti, 2002, Galantamine is efficacious in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease, Lancet, 329, 1283, 10.1016/s0140-6736(02)08267-3 · DOI · Paper page
- Tarrier N, Ward J, Burns A, Donaldson C, Barrowclough C. Expressed emotion and attributes in the carers of patients with Alzheimer's disease: the effect on carer burden. J Abnorm Psychol (in press).
Cited by
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 3,850
Self-citationGorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Self-citationPantoni, L. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70104-6 · Cited by 3,405
Self-citationGuidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
(2008) · Cerebrovascular Diseases · doi:10.1159/000131083 · Cited by 2,489
Metadata
- Authors
- O'Brien, J. T., Erkinjuntti, T., Reisberg, B., Roman, G., Sawada, T., Pantoni, L., Bowler, J. V., Ballard, C., DeCarli, C., Gorelick, P. B., Rockwood, K., Burns, A., Gauthier, S., & DeKosky, S. T.
- Affiliations
- Newcastle upon Tyne Hospital (GB)
- Helsinki University Hospital (FI)
- NYU Langone Health (US)
- The University of Texas at San Antonio Health Science Center (US)
- University of Florence (IT)
- The Royal Free Hospital (GB)
- University of California, Davis (US)
- Rush University Medical Center (US)
- Dalhousie University (CA)
- University of Manchester (GB)
- McGill University (CA)
- University of Pittsburgh (US)
- Corresponding author
- O'Brien, John T
- ORCID
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2003-02
- Volume
- 2
- Issue
- 2
- Pages
- 89-98
- ISSN
- 1474-4422 (ISSN-L)
- OpenAlex
- W4210993281
- Cited by
- 1,139
- References
- 92
- Citations by year
- 2026: 19 · 2025: 35 · 2024: 38 · 2023: 39 · 2022: 51 · 2021: 62 · 2020: 91 · 2019: 58 · 2018: 47 · 2017: 61 · 2016: 54 · 2015: 53 · 2014: 63 · 2013: 46 · 2012: 59
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet Neurology (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- European Commission
- National Institute of Neurological Disorders and Stroke (R01NS017950)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Keywords
- vascular cognitive impairment, cerebrovascular disease, dementia, mild cognitive impairment, multi-infarct dementia, post-stroke dementia, Alzheimer's disease, frontotemporal dementia, dementia with Lewy bodies, executive dysfunction, attentional impairment, depression, apathy, psychosis, diagnostic criteria
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vascular cognitive impairment. https://app.cochat.ai/papers/10.1016/s1474-4422(03)00305-3
- The paper
- O'Brien, J. T., Erkinjuntti, T., Reisberg, B., Roman, G., Sawada, T., Pantoni, L., Bowler, J. V., Ballard, C., DeCarli, C., Gorelick, P. B., Rockwood, K., Burns, A., Gauthier, S., & DeKosky, S. T. (2003). Vascular cognitive impairment. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(03)00305-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.